Marco Atteritano

Summary

Affiliation: University of Messina
Country: Italy

Publications

  1. ncbi Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Italy
    Eur J Pharmacol 589:22-6. 2008
  2. ncbi The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, University of Messina, AOU Policlinico G Martino, Via C Valeria, Messina, Italy
    Gene 508:206-10. 2012
  3. ncbi Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Italy
    J Clin Endocrinol Metab 92:3068-75. 2007
  4. ncbi Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, Section of Physiology and Human Nutrition, University of Messina, 98125 Messina, Italy
    J Clin Endocrinol Metab 93:4787-96. 2008
  5. ncbi Genistein aglycone does not affect thyroid function: results from a three-year, randomized, double-blind, placebo-controlled trial
    Alessandra Bitto
    Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology, University of Messina, 98125 Messina, Italy
    J Clin Endocrinol Metab 95:3067-72. 2010
  6. ncbi Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial
    Herbert Marini
    Azienda Ospedaliera Universitaria Policlinico G Martino, University of Messina, Messina, Italy
    Ann Intern Med 146:839-47. 2007
  7. ncbi Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study
    Maria Letizia Cannata
    Department of Obstetrical and Gynaecological Sciences, University of Messina, Messina, Italy
    Menopause 14:648-55. 2007
  8. ncbi The ESR2 AluI gene polymorphism is associated with bone mineral density in postmenopausal women
    Monica Currò
    Department of Biochemical, Physiological and Nutritional Sciences, University of Messina, Via C Valeria, Policlinico G Martino, 98124 Messina, Italy
    J Steroid Biochem Mol Biol 127:413-7. 2011
  9. ncbi Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer
    Nancy Morabito
    Department of Internal Medicine, University of Messina, Messina, Italy
    J Bone Miner Res 19:1766-70. 2004
  10. ncbi Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis
    Antonino Catalano
    Department of Internal Medicine, University of Messina, Messina, Italy
    Calcif Tissue Int 90:279-85. 2012

Collaborators

  • Alessandra Bitto
  • Rosario D'Anna
  • Giorgio Basile
  • Michele Buemi
  • Andrea Guala
  • Anna Meo
  • Onofrio Triolo
  • Vincenzo Adamo
  • Herbert Marini
  • Francesco Squadrito
  • Domenica Altavilla
  • Francesca Polito
  • Nicola Frisina
  • Maria Letizia Cannata
  • Agostino Gaudio
  • Letteria Minutoli
  • Francesco Corrado
  • Monica Currò
  • Antonino Catalano
  • Elena Bianca Adamo
  • Susanna Mazzaferro
  • Carla Lubrano
  • Francesco Cancellieri
  • Alessia Frisina
  • Nancy Morabito
  • Antonino Lasco
  • Elena B Adamo
  • Daniela Caccamo
  • Riccardo Ientile
  • Angela Alibrandi
  • Nadia Ferlazzo
  • Rolando Marini
  • Michele Bonaiuto
  • Steven Wilson
  • Nunziata Morabito
  • Domenico Cucinotta
  • Salvatore Condello
  • Vincenzo Di Stefano
  • Carlo Sansotta
  • Bruce P Burnett
  • Robert M Levy
  • Marianna Faraci
  • Giovanni Baviera
  • Francesco Antico
  • Roberta Guarino
  • Maria Cincotta
  • Darwin Melloni
  • Giuseppina Anastasi
  • Maria Antonia Pizzoleo
  • Aldo Trifiletti
  • Mariangela La Rosa

Detail Information

Publications12

  1. ncbi Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Italy
    Eur J Pharmacol 589:22-6. 2008
    ..The protective effect on genomic damage appears to be a particularly promising tool in reducing the risk of cancer...
  2. ncbi The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, University of Messina, AOU Policlinico G Martino, Via C Valeria, Messina, Italy
    Gene 508:206-10. 2012
    ..The present data strongly indicate that genotyping for the ESR2 AluI 1730G>A gene variant should be included in a screening panel for assessment of cardiovascular risk in menopausal women...
  3. ncbi Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Italy
    J Clin Endocrinol Metab 92:3068-75. 2007
    ..Genistein, a soy isoflavone, has received wide attention over the last few years because of its potential preventive role for cardiovascular disease...
  4. ncbi Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, Section of Physiology and Human Nutrition, University of Messina, 98125 Messina, Italy
    J Clin Endocrinol Metab 93:4787-96. 2008
    ..Genistein aglycone improves bone metabolism in women. However, questions about the long-term safety of genistein on breast as well as its continued efficacy still remain...
  5. ncbi Genistein aglycone does not affect thyroid function: results from a three-year, randomized, double-blind, placebo-controlled trial
    Alessandra Bitto
    Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology, University of Messina, 98125 Messina, Italy
    J Clin Endocrinol Metab 95:3067-72. 2010
    ..Genistein aglycone positively affects postmenopausal symptoms. However, questions about its long-term safety on the thyroid gland still remain...
  6. ncbi Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial
    Herbert Marini
    Azienda Ospedaliera Universitaria Policlinico G Martino, University of Messina, Messina, Italy
    Ann Intern Med 146:839-47. 2007
    ..Observational studies and small trials of short duration suggest that the isoflavone phytoestrogen genistein reduces bone loss, but the evidence is not definitive...
  7. ncbi Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study
    Maria Letizia Cannata
    Department of Obstetrical and Gynaecological Sciences, University of Messina, Messina, Italy
    Menopause 14:648-55. 2007
    ....
  8. ncbi The ESR2 AluI gene polymorphism is associated with bone mineral density in postmenopausal women
    Monica Currò
    Department of Biochemical, Physiological and Nutritional Sciences, University of Messina, Via C Valeria, Policlinico G Martino, 98124 Messina, Italy
    J Steroid Biochem Mol Biol 127:413-7. 2011
    ....
  9. ncbi Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer
    Nancy Morabito
    Department of Internal Medicine, University of Messina, Messina, Italy
    J Bone Miner Res 19:1766-70. 2004
    ..Neridronate, a relatively new bisphosphonate, is able to prevent bone loss in patients with prostate cancer during androgen ablation...
  10. ncbi Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis
    Antonino Catalano
    Department of Internal Medicine, University of Messina, Messina, Italy
    Calcif Tissue Int 90:279-85. 2012
    ..005 vs. placebo). Our data demonstrate that cholecalciferol at a dose of 300,000 IU reduces the intensity of musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis...
  11. ncbi Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle
    Nunziata Morabito
    Department of Internal Medicine, University of Messina, Messina, Italy
    J Bone Miner Res 19:722-7. 2004
    ..These data are extremely important for the possible therapeutic use of RANKL antagonists such as OPG in thalassemia-induced osteoporosis...
  12. ncbi OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, Section of Physiology and Human Nutrition, A O U Policlinico G Martino, Messina, Italy
    J Bone Miner Res 23:715-20. 2008
    ..Genistein, an isoflavone representing 1-5% of total phytoestrogen content in soybean products, may positively regulate cellular bone metabolism, but its mechanism of action on bone is not yet fully understood...